Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Therapeutic Potential of Ursolic Acid in Cancer and Diabetic Neuropathy Diseases
Manzar Alam, Sabeeha Ali, Sarfraz Ahmed, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 22, pp. 12162-12162
Open Access | Times Cited: 59

Showing 1-25 of 59 citing articles:

Epigallocatechin 3-gallate: From green tea to cancer therapeutics
Manzar Alam, Sabeeha Ali, Ghulam Md Ashraf, et al.
Food Chemistry (2022) Vol. 379, pp. 132135-132135
Closed Access | Times Cited: 162
Therapeutic Implications of Caffeic Acid in Cancer and Neurological Diseases
Manzar Alam, Sarfraz Ahmed, Abdelbaset Mohamed Elasbali, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 134
Biomedical features and therapeutic potential of rosmarinic acid
Saba Noor, Taj Mohammad, Malik Abdul Rub, et al.
Archives of Pharmacal Research (2022) Vol. 45, Iss. 4, pp. 205-228
Open Access | Times Cited: 131
Natural products can be used in therapeutic management of COVID-19: Probable mechanistic insights
Sabeeha Ali, Manzar Alam, Fatima Khatoon, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 147, pp. 112658-112658
Open Access | Times Cited: 73
Natural products of pentacyclic triterpenoids: from discovery to heterologous biosynthesis
Yanlin Li, Jing Wang, Linyong Li, et al.
Natural Product Reports (2022) Vol. 40, Iss. 8, pp. 1303-1353
Closed Access | Times Cited: 68
Bax/Bcl-2 Cascade Is Regulated by the EGFR Pathway: Therapeutic Targeting of Non-Small Cell Lung Cancer
Manzar Alam, Shoaib Alam, Anas Shamsi, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 61
Potential Therapeutic Implications of Caffeic Acid in Cancer Signaling: Past, Present, and Future
Manzar Alam, Ghulam Md Ashraf, Kayenat Sheikh, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 39
Epigallocatechin-3-Gallate Therapeutic Potential in Cancer: Mechanism of Action and Clinical Implications
Mateusz Kciuk, Manzar Alam, Nemat Ali, et al.
Molecules (2023) Vol. 28, Iss. 13, pp. 5246-5246
Open Access | Times Cited: 33
Therapeutic potential and novel formulations of ursolic acid and its derivatives: an updated review
Priya Namdeo, Bina Gidwani, Sakshi Tiwari, et al.
Journal of the Science of Food and Agriculture (2023) Vol. 103, Iss. 9, pp. 4275-4292
Closed Access | Times Cited: 25
Investigating regulated signaling pathways in therapeutic targeting of non-small cell lung carcinoma
Manzar Alam, Gulam Mustafa Hasan, Sayed M. Eldin, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 161, pp. 114452-114452
Open Access | Times Cited: 22
Biochemical features and therapeutic potential of α-Mangostin: Mechanism of action, medicinal values, and health benefits
Manzar Alam, Summya Rashid, Kisa Fatima, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 163, pp. 114710-114710
Open Access | Times Cited: 21
Exploring MTH1 inhibitory potential of Thymoquinone and Baicalin for therapeutic targeting of breast cancer
Aaliya Taiyab, Arunabh Choudhury, Shaista Haidar, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 173, pp. 116332-116332
Open Access | Times Cited: 9
Ursolic acid: a natural modulator of signaling networks in different cancers
Sameen Zafar, Khushbukhat Khan, Amna Hafeez, et al.
Cancer Cell International (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 31
Hybrid molecules based on caffeic acid as potential therapeutics: A focused review
Xue Zhi Zhao, Ziwei Liu, Hao Liu, et al.
European Journal of Medicinal Chemistry (2022) Vol. 243, pp. 114745-114745
Closed Access | Times Cited: 27
Therapeutic Targeting of Regulated Signaling Pathways of Non-Small Cell Lung Carcinoma
Gulam Mustafa Hasan, Md. Imtaiyaz Hassan, Sukhwinder Singh Sohal, et al.
ACS Omega (2023) Vol. 8, Iss. 30, pp. 26685-26698
Open Access | Times Cited: 15
Structure-guided design and development of cyclin-dependent kinase 4/6 inhibitors: A review on therapeutic implications
Mohd Yousuf, Manzar Alam, Anas Shamsi, et al.
International Journal of Biological Macromolecules (2022) Vol. 218, pp. 394-408
Closed Access | Times Cited: 25
Delving the Role of Caralluma fimbriata: An Edible Wild Plant to Mitigate the Biomarkers of Metabolic Syndrome
Rimsha Anwar, Roshina Rabail, Allah Rakha, et al.
Oxidative Medicine and Cellular Longevity (2022) Vol. 2022, pp. 1-17
Open Access | Times Cited: 23
Terpenes from Cecropia Species and Their Pharmacological Potential
Preslav Enchev, Yancho Zarev, Anzhelika Dakovska, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 3, pp. 399-399
Open Access | Times Cited: 3
Inhibition of PDK3 by artemisinin, a repurposed antimalarial drug in cancer therapy
Saleha Anwar, Debarati DasGupta, Naved Azum, et al.
Journal of Molecular Liquids (2022) Vol. 355, pp. 118928-118928
Closed Access | Times Cited: 20
Asiatic acid alleviates metabolism disorders in ob/ob mice: mechanistic insights
Kaixia Niu, Pengpeng Bai, Bingbing Yang, et al.
Food & Function (2022) Vol. 13, Iss. 13, pp. 6934-6946
Closed Access | Times Cited: 19
Investigating binding mechanism of thymoquinone to human transferrin, targeting Alzheimer's disease therapy
Bin Xue, Debarati DasGupta, Manzar Alam, et al.
Journal of Cellular Biochemistry (2022) Vol. 123, Iss. 8, pp. 1381-1393
Closed Access | Times Cited: 19
Natural Product-Inspired Targeted Protein Degraders: Advances and Perspectives
Jiao Li, Zhenyu Cai, Xu‐Wen Li, et al.
Journal of Medicinal Chemistry (2022) Vol. 65, Iss. 20, pp. 13533-13560
Closed Access | Times Cited: 19
Molecular Mechanism of Anti-Colorectal Cancer Effect of Hedyotis diffusa Willd and Its Extracts
Zihong Wu, Bei Yin, Fengming You
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 18
Inhibiting Cyclin-Dependent Kinase 6 by Taurine: Implications in Anticancer Therapeutics
Mohd Yousuf, Anas Shamsi, Taj Mohammad, et al.
ACS Omega (2022) Vol. 7, Iss. 29, pp. 25844-25852
Open Access | Times Cited: 18
Therapeutic targeting of TANK-binding kinase signaling towards anticancer drug development: Challenges and opportunities
Manzar Alam, Md. Meraj Ansari, Saba Noor, et al.
International Journal of Biological Macromolecules (2022) Vol. 207, pp. 1022-1037
Closed Access | Times Cited: 15
Page 1 - Next Page

Scroll to top